Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis

References

• LeBlanc DM, Barousse MM, Fidel PL, Jr. Role for dendritic cells in immunoregulation during experimental vaginal candidiasis. Infect Immun 2006; 74: 3213–3221
   Google Scholar
• Fidel PL, Jr. Immunity in vaginal candidiasis. Curr Opin Infect Dis 2005; 18: 107–111
   PubMedGoogle Scholar
• Fidel PL, Jr. Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 2002; 40: 359–375
   PubMed Web of Science ®Google Scholar
• Nomanbhoy F, Steele C, Yano J, Fidel PL, Jr. Vaginal and oral epithelial cell anti-Candida activity. Infect Immun 2002; 70: 7081–7088
   PubMed Web of Science ®Google Scholar
• Lilly EA, Leigh JE, Joseph SH, Fidel PL, Jr. Candida-induced oral epithelial cell responses. Mycopathologia 2006; 162: 25–32
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059–3069
   PubMed Web of Science ®Google Scholar
• Fidel PL, Jr, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403–2408
   PubMed Web of Science ®Google Scholar
• Little CH, Georgiou GM, Marceglia A, et al. Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis. Infect Immun 2000; 68: 3840–3847
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P, Bistoni F. Biological role of Th cell subsets in candidiasis. Chem Immunol 1996; 63: 115–137
   PubMedGoogle Scholar
• Cassone A, De Bernardis F, Torososantucci A. An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis. Curr Mol Med 2005; 5: 377–382
   PubMed Web of Science ®Google Scholar
• Han Y, Morrison RP, Cutler JE. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect Immun 1998; 66: 5771–5776
   PubMed Web of Science ®Google Scholar
• Magliani W, Conti S, Arseni S, et al. Antibody-mediated protective immunity in fungal infections. New Microbiol 2005; 28: 299–309
   PubMed Web of Science ®Google Scholar
• Magliani W, Conti S, Frazzi R, et al. Protective antifungal yeast killer toxin-like antibodies. Curr Mol Med 2005; 5: 443–452
   PubMed Web of Science ®Google Scholar
• Omaetxebarria MJ, Moragues MD, Elguezabal N, et al. Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans. Curr Mol Med 2005; 5: 393–401
   PubMed Web of Science ®Google Scholar
• Matthews RC, Burnie JP. Human recombinant antibody to HSP90: a natural partner in combination therapy. Curr Mol Med 2005; 5: 403–411
   PubMed Web of Science ®Google Scholar
• Pachl J, Svoboda P, Jacobs F, et al. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 2006; 42: 1404–1413
   PubMed Web of Science ®Google Scholar
• Raska M, Belakova J, Wudattu NK, et al. Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis. Folia Microbiol (Praha) 2005; 50: 77–82
   PubMed Web of Science ®Google Scholar
• Zhang G, Budker V, Wolff JA. High Levels of Foreign Gene Expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735–1737
   PubMed Web of Science ®Google Scholar
• Hamal P, Koukalova D, Hajek V. [Personal experience with classification of yeast microorganisms. I. The combined biotyping method of Mencl and Otcenasek and typing using the ‘killer’ phenomenon]. Epidemiol Mikrobiol Imunol 1998; 47: 87–92
   PubMedGoogle Scholar
• Yang Q, Wang L, Lu DN, et al. Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice. Vaccine 2005; 23: 4088–4096
   PubMed Web of Science ®Google Scholar
• Balmelli C, Roden R, Potts A, et al. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol 1998; 72: 8220–8229
   PubMed Web of Science ®Google Scholar
• Nardelli-Haefliger D, Wirthner D, Schiller JT, et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003; 95: 1128–1137
   PubMed Web of Science ®Google Scholar
• Johansson EL, Wassen L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001; 69: 7481–7486
   PubMed Web of Science ®Google Scholar
• Raska M, Belakova J, Krupka M, Weigl E. Candidiasis – do we need to fight or to tolerate the Candida fungus?. Folia Microbiol (Praha) 2007; 52: 297–312
   PubMed Web of Science ®Google Scholar
• De Bernardis F, Boccanera M, Adriani D, Girolamo A, Cassone A. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis. Infect Immun 2002; 70: 2725–2729
   PubMed Web of Science ®Google Scholar
• Romani L, Mencacci A, Cenci E, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1345–1355
   PubMed Web of Science ®Google Scholar
• Wozniak KL, Wormley FL, Jr, Fidel PL, Jr. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun 2002; 70: 5790–5799
   PubMed Web of Science ®Google Scholar
• Torosantucci A, Bromuro C, Chiani P, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005; 202: 597–606
   PubMed Web of Science ®Google Scholar
• Polonelli L, Lorenzini R, De Bernardis F, Morace G. Potential therapeutic effect of yeast killer toxin. Mycopathologia 1986; 96: 103–107
   PubMed Web of Science ®Google Scholar
• De Bernardis F, Boccanera M, Adriani D, et al. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 1997; 65: 3399–3405
   PubMed Web of Science ®Google Scholar
• Matthews RC, Burnie JP. Recombinant antibodies: a natural partner in combinatorial antifungal therapy. Vaccine 2004; 22: 865–871
   PubMed Web of Science ®Google Scholar
• Soti C, Racz A, Csermely P. A Nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. J Biol Chem 2002; 277: 7066–7075
   PubMed Web of Science ®Google Scholar
• Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001; 9: 327–335
   PubMed Web of Science ®Google Scholar
• Matthews R, Burnie JP, Lee W. The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Methods 1991; 143: 73–79
   PubMed Web of Science ®Google Scholar
• Matthews RC, Burnie JP, Howat D, Rowland T, Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 1991; 74: 20–24
   PubMed Web of Science ®Google Scholar
• Wang G, Sun M, Fang J, et al. Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice. Vaccine 2006; 24: 6065–6073
   PubMed Web of Science ®Google Scholar
• Matthews R, Hodgetts S, Burnie J. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J Infect Dis 1995; 171: 1668–1671
   PubMed Web of Science ®Google Scholar
• Matthews RC, Rigg G, Hodgetts S, et al. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob Agents Chemother 2003; 47: 2208–2216
   PubMed Web of Science ®Google Scholar
• Liu MA, Wahren B, Karlsson Hedestam GB. DNA vaccines: recent developments and future possibilities. Hum Gene Ther 2006; 17: 1051–1061
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Wahren B, Liu MA. Gene-based vaccines: recent technical and clinical advances. Trends Mol Med 2006; 12: 216–222
   PubMed Web of Science ®Google Scholar
• Vorup-Jensen T, Jensen UB, Liu H, et al. Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver. Mol Ther 2001; 3: 867–874
   PubMed Web of Science ®Google Scholar
• Bates MK, Zhang G, Sebestyen MG, et al. Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA. Biotechniques 2006; 40: 199–208
   PubMed Web of Science ®Google Scholar
• Silver PB, Agarwal RK, Su SB, et al. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol 2007; 179: 5146–5158
   PubMed Web of Science ®Google Scholar